EPIQ Isolate (Chocolate)
Natural health product licensed in Canada
- Licence holder
- Iovate Health Sciences International Inc.
- NPN or DIN-HM
- 80059175
- Status
- Active licence
- Licence date
- 25 March 2015
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Isolat de protéine de soja Source : Glycine max - Graine | 11.56 g | Not calculated |
| Isolat de protéine de soja Source : Isolat de protéine de soja | 11.56 g | Not calculated |
| Isolat de protéine de soja Source : Glycine max - Graine | 29.8 mg ÉAI | Not calculated |
| Isolat de protéine de soja Source : Isolat de protéine de soja | 29.8 mg ÉAI | Not calculated |
| Isolat de protéine de lait Source : Bos taurus - Lait | 82 % | Not calculated |
| Isolat de protéine de lait Source : Isolat de protéine de lait | 82 % | Not calculated |
| Isolat de protéine de lait Source : Bos taurus - Lait | 11.5 g | Not calculated |
| Isolat de protéine de lait Source : Isolat de protéine de lait | 11.5 g | Not calculated |
| Papaïne Source : Carica papaya - Latex | 100 FCC PU | Not calculated |
| Papaïne Source : Papain | 100 FCC PU | Not calculated |
| Papaïne Source : Carica papaya - Latex | 50 mg | Not calculated |
| Papaïne Source : Papain | 50 mg | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Alpha-amylase | 50 mg | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 50 mg | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Alpha-amylase | 250 Unités d'alpha-amylase dextrinifiante du FCC | Not calculated |
| 4-alpha-D-glucane glucanohydrolase Source : Aspergillus flavus var. oryzae - En entier | 250 Unités d'alpha-amylase dextrinifiante du FCC | Not calculated |
| Isolat de protéine de lactosérum Source : Isolat de protéine de lactosérum Potency : 89 % Whey protein | 10 mg | Not calculated |
| Isolat de protéine de lactosérum Source : Bos taurus - Lait Potency : 89 % Whey protein | 10 mg | Not calculated |
| Hydrolysat de protéine du lactosérum Source : Hydrolysat de protéine du lactosérum Potency : 88 % Whey protein | 10 mg | Not calculated |
| Hydrolysat de protéine du lactosérum Source : Bos taurus - Lait Potency : 88 % Whey protein | 10 mg | Not calculated |
| Isolat de protéine de lactosérum Source : Bos taurus - Lait Potency : 91 % Whey protein | 10 mg | Not calculated |
| Isolat de protéine de lactosérum Source : Isolat de protéine de lactosérum Potency : 91 % Whey protein | 10 mg | Not calculated |
Non-medicinal ingredients
Sucralose, Saveur de chocolat noir, Saveur de beurre, Saveur de crème, Maltodextrine, Acésulfame potassium, Poudre de cacao
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Mesures | minimum: 1 Tous les jours ; maximum: 2 Tous les jours |
Uses authorised in Canada
Source of digestive enzymes. Workout supplement. Athletic support. Source of protein for the maintenance of good health. Source of protein which helps build and repair body tissues. Source of amino acids involved in muscle protein synthesis. Assists in the building of lean muscle [tissue/mass] when combined with regular [weight/resistance] training and a healthy balanced diet.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity/allergy has been known to occur, in which case discontinue use.
- Contre-indications
Do not use if you currently have or previously had breast cancer and/or breast tumours or if you have a predisposition to breast cancer, as indicated by an abnormal mammogram and/or biopsy, or a family member with breast cancer.
- Précautions et mises en garde
If you are pregnant or breastfeeding, consult a health care practitioner prior to use. If you have diabetes, liver or kidney disease, consult a health care practitioner prior to use. If you have a gastrointestinal lesion/ulcer, are taking an anticoagulant/blood thinner or an anti-inflammatory, or are having surgery, consult a health care practitioner prior to use. If you have allergy to latex or fruits (such as avocado, banana, chestnut, passion fruit, fig, melon, mango, kiwi, pineapple, peach, and tomato), consult a health care practitioner prior to use. Ensure you are up-to-date on mammograms and gynaecological evaluations prior to use. Consult a health care practitioner prior to use if you are taking blood thinners. Consult a health care practitioner prior to use if you have a history of hormonal or gynaecological disease, including ovarian cancer, endometriosis, and/or uterine fibroids. Consult a health care practitioner prior to use if you have a liver disorder or develop liver-related symptoms (e.g. abdominal pain, jaundice, dark urine). Consult a health care practitioner prior to use if you are taking hormone replacement therapy (HRT), including thyroid hormone replacement therapy. Discontinue use and consult a health care practitioner if you are experiencing breast pain, discomfort and/or tenderness, or if you experience a recurrence if menstruation or uterine spotting.
Source
Official Health Canada record, licence 80059175
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.